<p style="text-align: justify;">OBJECTIVES: This study evaluated the prevalence of anxiety, depression, and posttraumatic growth (positive psychological change as a result of the struggle with highly challenging life circumstances) among patients with HIV/AIDS as well as determine the correlation between these variables alongside select sociodemographic variables.
METHODOLOGY: Fifty eight patients enrolled in an HIV/AIDS clinic at a tertiary hospital were selected via convenience sampling and asked to complete a sociodemographic questionnaire, the Posttraumatic Growth Inventory (PTGI) and the Hospital Anxiety and Depression Scale (HADS) from July to October 2015.
RESULTS: Ninety three percent of the participants reported moderate to high levels of posttraumatic growth, with a mean score of 4.70 (SD = 0.86). 20.7% (11.2 - 33.4, CL=95%) of patients screened positive for depression while 55.2% (41.5 - 68.3, CL=95%) of patients screened positive for anxiety. A statistically significant negative corellation was demonstrated between posttraumatic growth and depression (r=-0.29, p-value= 0.027) but not for anxiety (r=.027, p-value= 0.118).
CONCLUSION: There is a high prevalence of patients in the sample that exhibit depression and anxiety symptoms. Despite this, most patients report a capacity to experience positive changes in the aftermath of a life-threatening, chronic, and stigmatizing illness, correlating with a decrease in depressive symptomatology. As such, initiatives promoting posttraumatic growth are valuable in the comprehensive care for patients afflicted with HIV/AIDS.p>
Human ; Male ; Female ; Depression ; Prevalence ; Tertiary Care Centers ; Acquired Immunodeficiency Syndrome ; 4-amino-4'-hydroxylaminodiphenylsulfone ; Anxiety ; Depressive Disorder ; Anxiety Disorders

<p style="text-align: justify;">OBJECTIVES: This study evaluated the prevalence of anxiety, depression, and posttraumatic growth (positive psychological change as a result of the struggle with highly challenging life circumstances) among patients with HIV/AIDS as well as determine the correlation between these variables alongside select sociodemographic variables.
METHODOLOGY: Fifty eight patients enrolled in an HIV/AIDS clinic at a tertiary hospital were selected via convenience sampling and asked to complete a sociodemographic questionnaire, the Posttraumatic Growth Inventory (PTGI) and the Hospital Anxiety and Depression Scale (HADS) from July to October 2015.
RESULTS: Ninety three percent of the participants reported moderate to high levels of posttraumatic growth, with a mean score of 4.70 (SD = 0.86). 20.7% (11.2 - 33.4, CL=95%) of patients screened positive for depression while 55.2% (41.5 - 68.3, CL=95%) of patients screened positive for anxiety. A statistically significant negative corellation was demonstrated between posttraumatic growth and depression (r=-0.29, p-value= 0.027) but not for anxiety (r=.027, p-value= 0.118).
CONCLUSION: There is a high prevalence of patients in the sample that exhibit depression and anxiety symptoms. Despite this, most patients report a capacity to experience positive changes in the aftermath of a life-threatening, chronic, and stigmatizing illness, correlating with a decrease in depressive symptomatology. As such, initiatives promoting posttraumatic growth are valuable in the comprehensive care for patients afflicted with HIV/AIDS.p>
Human ; Male ; Female ; Depression ; Anxiety ; Hiv ; Prevalence ; Posttraumatic Growth, Psychological ; Depressive Disorder ; Anxiety Disorders ; Tertiary Healthcare